Market Cap 227.78M
Revenue (ttm) 51.29M
Net Income (ttm) -59.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -116.92%
Debt to Equity Ratio 0.85
Volume 388,200
Avg Vol 228,122
Day's Range N/A - N/A
Shares Out 26.15M
Stochastic %K 91%
Beta 1.26
Analysts Strong Sell
Price Target $10.83

Company Profile

CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, a neuromodulation device that enhance symptoms for patients with heart failure by delivering electrical pulses to baroreceptors. It sells its products through direct sales force, sales agents, and independent distributors. The company was...

Industry: Medical Devices
Sector: Healthcare
Phone: 763 416 2840
Fax: 763 416 2841
Address:
9201 West Broadway Avenue, Suite 650, Minneapolis, United States
commoncentsinvestor
commoncentsinvestor Oct. 2 at 5:19 PM
$CVRX What is CVRX share price value?Using traditional methods for valuation, CVRX would appear to be quite undervalued at around $8. Some key factors: "The gross margin for implantable medical device companies varies, but strong, large players can achieve margins exceeding 20% or even 30%." CVRX has been producing Gross Margins of around 80%. "Average Price to Sales ratio for Medical Device companies is 4.4." With Gross Margins of more than double the average, it would not seem extreme to assign a P/S ratio for CVRX of 8. Using historical revenue figures has shown that average revenue per implant center is about $286,000. CVRX started 2025 with 233 implant centers so normal revenue total for the year would be about $67M. Using that figure a P/S ratio of 8, and outstanding shares of 26M, a fair value for CVRX shares would be $20.60. Since CVRX is still not profitable and in an unstable economy and market, taking 25% off that figure would bring it to about $15 per share.
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:37 AM
$CVRX We’ve completed our 20th Barostim placement for CHF treatment. This achievement highlights innovation, teamwork, and most importantly—hope for patients. Great job team! https://x.com/HCrespoSotoMD/status/1973205542555492722
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:36 AM
$CVRX We were proud to support Dr. Tim Fuller, Travis Polk, NP, and the team at Banner North Colorado Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1973146795539832838
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:34 AM
$CVRX Barostim Baroreflex (Activation Therapy) is an innovative, FDA-approved implantable medical device, the world’s first neuromodulation device specifically for heart failure management, using gentle electrical pulses to activate the body’s natural baroreflex system—the mechanism that helps regulate blood pressure, heart rate, and vascular function. https://x.com/noble_road/status/1973140769155264638
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:33 AM
$CVRX Mega Doctor News @MegaDoctor · Sep 30 Earlier this month, Dr. Luis Reyes, a board-certified general, vascular and bariatric surgeon affiliated with STHS Heart, performed the first Barostim NEO® implant at the facility on a 57-year-old male patient living with congestive heart failure. https://x.com/MegaDoctor/status/1972891893181604170
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 1 at 1:04 PM
$CVRX CBS NEWS California man on track to ski again after recovery from "widowmaker" heart attack https://www.cbsnews.com/sacramento/news/placeville-skier-widowmaker-heart-attack-barostim-device-recovery/
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:59 PM
$BKD Brookdale Senior Living Trades: 14 | Total $: 16.7 K | 0.62 × 90-Day Avg $: 27.2 K | Call $: 221 | Put $: 16.5 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $INTA Intapp Trades: 6 | Total $: 6.1 K | 0.11 × 90-Day Avg $: 57.6 K | Call $: 220 | Put $: 5.8 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $NSA National Storage Affiliates Trust Trades: 2 | Total $: 265 | 0.14 × 90-Day Avg $: 1.9 K | Call $: 220 | Put $: 45 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CVRX CVRX Trades: 3 | Total $: 220 | 0.02 × 90-Day Avg $: 9.8 K | Call $: 220 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 30 at 2:28 PM
$CVRX Congratulations to @DmitryYaranovMD , Andrea Wallace, MSN, FNP-C, HF-Cert, FHFSA, Dr. Frank McGrew and the team at Baptist Memorial Hospital Memphis on successfully completing their 75th #Barostim implant! Thank you for advancing #heartfailure care by providing innovative therapy options to your patients. https://x.com/amitalamMD/status/1972845371354464444
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 30 at 2:20 PM
$CVRX STHS Heart is the First RGV Facility to Successfully Implant Innovative, Heart Failure Treatment Device https://megadoctornews.com/sths-heart-is-the-first-rgv-facility-to-successfully-implant-innovative-heart-failure-treatment-device/
0 · Reply
MedDevice
MedDevice Sep. 29 at 1:50 PM
$CVRX important to delineate revenue from implants based on the flat revenue growth for active centers. How likely is it that new centers are all producing the same amount of implants, not exceeding 2 per quarter? The consistent factor here may be stocking orders.
0 · Reply
Latest News on CVRX
CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 7:27 PM EDT - 2 months ago

CVRx, Inc. (CVRX) Q2 2025 Earnings Call Transcript


CVRx Announces Positive News on Outpatient Payment for Barostim

Jul 16, 2025, 7:30 AM EDT - 2 months ago

CVRx Announces Positive News on Outpatient Payment for Barostim


CVRx: Sell-Off Ignores Its True Potential

Jul 2, 2025, 4:02 AM EDT - 3 months ago

CVRx: Sell-Off Ignores Its True Potential


CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript

May 10, 2025, 3:51 PM EDT - 5 months ago

CVRx, Inc. (CVRX) Q1 2025 Earnings Conference Call Transcript


CVRx Inc: Overreaction Creates Buying Opportunity

Apr 9, 2025, 8:45 AM EDT - 6 months ago

CVRx Inc: Overreaction Creates Buying Opportunity


CVRx Reports Preliminary First Quarter 2025 Financial Results

Apr 7, 2025, 4:05 PM EDT - 6 months ago

CVRx Reports Preliminary First Quarter 2025 Financial Results


CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript

Feb 4, 2025, 11:00 PM EST - 8 months ago

CVRx, Inc. (CVRX) Q4 2024 Earnings Conference Call Transcript


CVRx: Impressive Top-Line Growth Seems Priced In

Nov 6, 2024, 9:04 PM EST - 11 months ago

CVRx: Impressive Top-Line Growth Seems Priced In


CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript

Oct 29, 2024, 10:38 PM EDT - 1 year ago

CVRx, Inc. (CVRX) Q3 2024 Earnings Call Transcript


CVRx announces new CPT® Category I codes for Barostim

Oct 18, 2024, 2:08 PM EDT - 1 year ago

CVRx announces new CPT® Category I codes for Barostim


CVRx Announces Appointment of Two New Board Members

Sep 3, 2024, 8:30 AM EDT - 1 year ago

CVRx Announces Appointment of Two New Board Members


commoncentsinvestor
commoncentsinvestor Oct. 2 at 5:19 PM
$CVRX What is CVRX share price value?Using traditional methods for valuation, CVRX would appear to be quite undervalued at around $8. Some key factors: "The gross margin for implantable medical device companies varies, but strong, large players can achieve margins exceeding 20% or even 30%." CVRX has been producing Gross Margins of around 80%. "Average Price to Sales ratio for Medical Device companies is 4.4." With Gross Margins of more than double the average, it would not seem extreme to assign a P/S ratio for CVRX of 8. Using historical revenue figures has shown that average revenue per implant center is about $286,000. CVRX started 2025 with 233 implant centers so normal revenue total for the year would be about $67M. Using that figure a P/S ratio of 8, and outstanding shares of 26M, a fair value for CVRX shares would be $20.60. Since CVRX is still not profitable and in an unstable economy and market, taking 25% off that figure would bring it to about $15 per share.
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:37 AM
$CVRX We’ve completed our 20th Barostim placement for CHF treatment. This achievement highlights innovation, teamwork, and most importantly—hope for patients. Great job team! https://x.com/HCrespoSotoMD/status/1973205542555492722
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:36 AM
$CVRX We were proud to support Dr. Tim Fuller, Travis Polk, NP, and the team at Banner North Colorado Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1973146795539832838
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:34 AM
$CVRX Barostim Baroreflex (Activation Therapy) is an innovative, FDA-approved implantable medical device, the world’s first neuromodulation device specifically for heart failure management, using gentle electrical pulses to activate the body’s natural baroreflex system—the mechanism that helps regulate blood pressure, heart rate, and vascular function. https://x.com/noble_road/status/1973140769155264638
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 2 at 2:33 AM
$CVRX Mega Doctor News @MegaDoctor · Sep 30 Earlier this month, Dr. Luis Reyes, a board-certified general, vascular and bariatric surgeon affiliated with STHS Heart, performed the first Barostim NEO® implant at the facility on a 57-year-old male patient living with congestive heart failure. https://x.com/MegaDoctor/status/1972891893181604170
0 · Reply
commoncentsinvestor
commoncentsinvestor Oct. 1 at 1:04 PM
$CVRX CBS NEWS California man on track to ski again after recovery from "widowmaker" heart attack https://www.cbsnews.com/sacramento/news/placeville-skier-widowmaker-heart-attack-barostim-device-recovery/
0 · Reply
highnihilism
highnihilism Oct. 1 at 12:59 PM
$BKD Brookdale Senior Living Trades: 14 | Total $: 16.7 K | 0.62 × 90-Day Avg $: 27.2 K | Call $: 221 | Put $: 16.5 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $INTA Intapp Trades: 6 | Total $: 6.1 K | 0.11 × 90-Day Avg $: 57.6 K | Call $: 220 | Put $: 5.8 K | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $NSA National Storage Affiliates Trust Trades: 2 | Total $: 265 | 0.14 × 90-Day Avg $: 1.9 K | Call $: 220 | Put $: 45 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: – $CVRX CVRX Trades: 3 | Total $: 220 | 0.02 × 90-Day Avg $: 9.8 K | Call $: 220 | Put $: 0 | Single-Leg: 100% | Multi-Leg: 0% | Contingent: –
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 30 at 2:28 PM
$CVRX Congratulations to @DmitryYaranovMD , Andrea Wallace, MSN, FNP-C, HF-Cert, FHFSA, Dr. Frank McGrew and the team at Baptist Memorial Hospital Memphis on successfully completing their 75th #Barostim implant! Thank you for advancing #heartfailure care by providing innovative therapy options to your patients. https://x.com/amitalamMD/status/1972845371354464444
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 30 at 2:20 PM
$CVRX STHS Heart is the First RGV Facility to Successfully Implant Innovative, Heart Failure Treatment Device https://megadoctornews.com/sths-heart-is-the-first-rgv-facility-to-successfully-implant-innovative-heart-failure-treatment-device/
0 · Reply
MedDevice
MedDevice Sep. 29 at 1:50 PM
$CVRX important to delineate revenue from implants based on the flat revenue growth for active centers. How likely is it that new centers are all producing the same amount of implants, not exceeding 2 per quarter? The consistent factor here may be stocking orders.
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 28 at 1:10 PM
$CVRX We're honored to partner with Dr. Jesus Ulloa, Dr. Hugh Gelabert, Dr. Freny Mody, Sarah Goldberg, NP, and the team at West Los Angeles VA Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://www.linkedin.com/posts/cvrx_west-la-va-barostim-implant-activity-7377421689049157632-P2lH
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 27 at 10:19 PM
$CVRX Congratulations to Dr. Stephen Raulli, Dr. Priyesh Patel and the team at @AtriumHealth Pineville on their 20th #Barostim implant! Thanks for your dedication to providing innovative therapy options to improve the lives of patients with #heartfailure. https://x.com/search?q=barostim&src=recent_search_click
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 27 at 10:16 PM
$CVRX Banner Health (North Colorado Medical Center) Dr. Tim Fuller, medical director of vascular services at Banner Health in Northern Colorado, implanted the first Barostim device in the region. This device is designed to treat heart failure. https://www.facebook.com/BannerNorthColoradoMedicalCenter/photos/dr-tim-fuller-medical-director-of-vascular-services-at-banner-health-in-northern/1461776732142695/
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 25 at 12:50 PM
$CVRX We're proud to support Dr. Timothy Brand, Dr. Kobina Wilmot, Jennifer Harris, NP, and the team at Novant Health Presbyterian Medical Center on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/search?q=barostim&src=recent_search_click&f=live
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 25 at 12:49 PM
$CVRX Frederik Meijer Heart & Vascular Institute @FM_HVI · 22h 🚨 First @CVRx_Barostim implant at Corewell Health in West Michigan - a milestone made possible by our incredible AHF and vascular teams! We're expanding access to advanced HF device therapies for patients across the spectrum of heart failure. More innovation ahead. Stay tuned! https://x.com/search?q=barostim&src=recent_search_click&f=live
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 22 at 6:44 PM
$CVRX We were honored to partner with Dr. Juan Posada, Dr. Luis Reyes, and the team at McAllen Heart Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1970151410843996446
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 22 at 6:41 PM
$CVRX We were honored to partner with Dr. Juan Posada, Dr. Luis Reyes, and the team at McAllen Heart Hospital on their first #Barostim implant. Their patients now have access to a novel device therapy to improve symptoms of #heartfailure. https://x.com/CVRx_Barostim/status/1970151410843996446
0 · Reply
commoncentsinvestor
commoncentsinvestor Sep. 22 at 6:38 PM
$CVRX Congratulations to the team at @HMHNewJersey Jersey Shore University Medical Center for successfully completing 35 #Barostim implants! Special thanks to Dr. Jesus Almendral, Dr. Cynthia Kos, Dr. Matt Samra, and Dreamy James, DNP, for your dedication to bringing innovative therapy options to patients with #heartfailure. https://x.com/CVRx_Barostim/status/1969119104343658542
0 · Reply
highnihilism
highnihilism Sep. 22 at 1:04 PM
IWM: Russell 2000 → $SVC Service Properties Trust $ALNT Allient $CMTG Claros Mortgage Trust $CVRX CVRX $CCB Coastal Financial
0 · Reply
JanWilliams702
JanWilliams702 Sep. 21 at 7:30 AM
$CVRX Medical device innovation. Regulatory catalyst upcoming. High short interest. Volatility expected.
1 · Reply
highnihilism
highnihilism Sep. 17 at 8:56 AM
IWM: Russell 2000 → $ALNT Allient $CVRX CVRX $CCB Coastal Financial $FLYW Flywire $GCO Genesco
0 · Reply
highnihilism
highnihilism Sep. 16 at 7:58 PM
IWM: Russell 2000 → $SVC Service Properties Trust $ALNT Allient $CMTG Claros Mortgage Trust $CVRX CVRX $CCB Coastal Financial
0 · Reply